Latest filing published 28 Jun 2019 for NextCell Pharma AB, €4,677.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Leo Cornelis Groenewegen: trading record in brief
This profile gathers the share dealings of Leo Cornelis Groenewegen in NextCell Pharma AB. Over a trading history stretching from 27 September 2017 to 28 June 2019, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €1,065 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 28 June 2019 came the latest disclosure, a transaction for €4,677 in NextCell Pharma AB. The most recent open-market purchase was published on 28 September 2017, 3,329 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Leo Cornelis Groenewegen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,182 shares@ SEK 3.2557.5% of flowBTA (betald tecknad aktie)ISIN SE0012702538FI:csv-581afe4d4f443cd14fe0
- 5,050 shares0ISIN SE0009888795FI:csv-2f338f6fc01d99861adb
- 4,250 shares@ SEK 2.4013.1% of flowISIN SE0009888795FI:csv-3b6d524244b785354fe5Canonical exit: 26 Dec 2017 (T+90)
3 of 3 declarations